IL198169A0 - Robust sustained release formulations of oxymorphone - Google Patents

Robust sustained release formulations of oxymorphone

Info

Publication number: IL198169A0
Authority: IL; Israel
Prior art keywords: oxymorphone; sustained release; release formulations; robust sustained; robust
Prior art date: 2006-10-10

Application number

IL198169A

Other languages

English (en)

Original Assignee

Penwest Pharmaceuticals Compan

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-10

Filing date

2009-04-16

Publication date

2009-12-24

2009-04-16 Application filed by Penwest Pharmaceuticals Compan filed Critical Penwest Pharmaceuticals Compan

2009-12-24 Publication of IL198169A0 publication Critical patent/IL198169A0/en

Links

UQCNKQCJZOAFTQ-ISWURRPUSA-N Oxymorphone Chemical compound O([C@H]1C(CC[C@]23O)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O UQCNKQCJZOAFTQ-ISWURRPUSA-N 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
229960005118 oxymorphone Drugs 0.000 title 1
238000013268 sustained release Methods 0.000 title 1
239000012730 sustained-release form Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL198169A 2006-10-10 2009-04-16 Robust sustained release formulations of oxymorphone IL198169A0 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2006/039767 WO2008045046A1 (en)	2006-10-10	2006-10-10	Robust sustained release formulations of oxymorphone

Publications (1)

Publication Number	Publication Date
IL198169A0 true IL198169A0 (en)	2009-12-24

Family

ID=38169509

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL198169A IL198169A0 (en)	2006-10-10	2009-04-16	Robust sustained release formulations of oxymorphone

Country Status (10)

Country	Link
EP (1)	EP2097069A1 (pt)
JP (1)	JP2010505947A (pt)
KR (1)	KR20090076946A (pt)
CN (1)	CN101578095A (pt)
AU (1)	AU2006349471A1 (pt)
BR (1)	BRPI0621952A2 (pt)
CA (1)	CA2652980A1 (pt)
IL (1)	IL198169A0 (pt)
MX (1)	MX2009003772A (pt)
WO (1)	WO2008045046A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9820982B2 (en)	2001-07-06	2017-11-21	Endo Pharmaceuticals Inc.	Oxymorphone controlled release formulations
MX2009003770A (es) *	2006-10-10	2009-07-22	Penwest Pharmaceuticals Co	Formulaciones de oximorfona robustas, de liberacion sostenida y metodos para su uso.
EP3473246A1 (en)	2017-10-19	2019-04-24	Capsugel Belgium NV	Immediate release abuse deterrent formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9820982B2 (en) *	2001-07-06	2017-11-21	Endo Pharmaceuticals Inc.	Oxymorphone controlled release formulations
BR0210855A (pt) *	2001-07-06	2006-10-24	Penwest Pharmaceuticals Compan	Método de fabricação de formulações de liberação prolongada
CA2459976A1 (en) *	2001-09-26	2003-04-03	Penwest Pharmaceuticals Company	Opioid formulations having reduced potential for abuse
MX2009003770A (es) *	2006-10-10	2009-07-22	Penwest Pharmaceuticals Co	Formulaciones de oximorfona robustas, de liberacion sostenida y metodos para su uso.

2006
- 2006-10-10 MX MX2009003772A patent/MX2009003772A/es not_active Application Discontinuation
- 2006-10-10 CA CA002652980A patent/CA2652980A1/en not_active Abandoned
- 2006-10-10 KR KR1020097008716A patent/KR20090076946A/ko not_active Ceased
- 2006-10-10 WO PCT/US2006/039767 patent/WO2008045046A1/en not_active Ceased
- 2006-10-10 AU AU2006349471A patent/AU2006349471A1/en not_active Abandoned
- 2006-10-10 BR BRPI0621952-7A patent/BRPI0621952A2/pt not_active Application Discontinuation
- 2006-10-10 JP JP2009532329A patent/JP2010505947A/ja active Pending
- 2006-10-10 CN CNA2006800560524A patent/CN101578095A/zh active Pending
- 2006-10-10 EP EP06816745A patent/EP2097069A1/en not_active Withdrawn
2009
- 2009-04-16 IL IL198169A patent/IL198169A0/en unknown

Also Published As

Publication number	Publication date
CA2652980A1 (en)	2008-04-17
KR20090076946A (ko)	2009-07-13
BRPI0621952A2 (pt)	2011-10-18
MX2009003772A (es)	2009-07-22
EP2097069A1 (en)	2009-09-09
AU2006349471A1 (en)	2008-04-17
CN101578095A (zh)	2009-11-11
JP2010505947A (ja)	2010-02-25
WO2008045046A1 (en)	2008-04-17

Publication	Publication Date	Title
IL198168A0 (en)	2009-12-24	Robust sustained release formulations
IL216401A0 (en)	2011-12-29	Sustained release of antinfectives
GB2435419B (en)	2008-03-05	Formulations
IL184460A0 (en)	2007-10-31	Sustained release pharmaeutical formulations
EP2046930A4 (en)	2012-06-27	FORMULATIONS BASED ON RHAMNOLIPIDS
PT1931315E (pt)	2014-01-03	Formulações de libertação sustentada de nalbufina
IL178596A0 (en)	2007-02-11	Sustained release formulations
EP1976488A4 (en)	2010-02-10	ALFUZOSIN PROLONGED RELEASE PREPARATIONS
GB0718409D0 (en)	2007-10-31	Formulations
GB0605780D0 (en)	2006-05-03	Formulations
ZA200810178B (en)	2009-12-30	Pharmaceutical compositions for sustained release of phenyephrine
EP1895991A4 (en)	2012-11-07	MODIFIED RELEASE FORMULATIONS OF ANTI-IRRITABLE DRUGS
GB0610336D0 (en)	2006-07-05	Formulations
GB0615108D0 (en)	2006-09-06	Novel formulations
IL198170A0 (en)	2009-12-24	Robust sustained release formulations of oxymorphone and methods of use thereof
EP2000152A4 (en)	2013-01-23	SOLID PREPARATION WITH IMPROVED SOLUBILITY
GB0718404D0 (en)	2007-10-31	Formulations
EP1871348A4 (en)	2012-08-01	PHARMACEUTICAL COMPOSITIONS WITH DELAYED RELEASE
ZA200807682B (en)	2009-11-25	Novel formulations
HK1129325A (en)	2009-11-27	Robust sustained release formulations of oxymorphone
ZA200902096B (en)	2010-09-29	Robust sustained release formulations
GB0722040D0 (en)	2007-12-19	Sustained release methotrexate formulations and methods of use thereof
HK1130432A (en)	2009-12-31	Robust sustained release formulations of oxymorphone and methods of use thereof
HK1133581A (en)	2010-04-01	Robust sustained release formulations
HK1126661A (en)	2009-09-11	Ethanol-resistant sustained release formulations